Stopped early
Treatment of Depression With Connectivity Guided Robotically Delivered rTMS
NCT02802293 · The University of Texas Health Science Center at San Antonio · Updated 25 Aug 2022
- What is being tested
- repetitive transcranial magnetic stimulation; robotic arm
- For
- Major Depressive Disorder
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 65 years. About 10 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 17 Aug 2017, ends 23 March 2021. Registered 16 June 2016.
- Results
- Posted on the registry on 25 Aug 2022.
In the researchers' words
The purpose of this study is to determine the clinical effects (if any) of connectivity-guided repetitive transcranial magnetic stimulation (rTMS) in the treatment of major depressive disorder (MDD) to provide clues about the ideal neural networks to target for more robust clinical outcomes, and to identify potential biomarkers of treatment response including changes in brain network connectivity.
Sites
- Ikare, Mood, Trauma, Recovery ClinicSan Antonio, Texas, United States